{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:46:28Z","timestamp":1792111588306,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rare bleeding disorders (RBDs) include fibrinogen (Factor I), prothrombin (Factor II), Factor V(FV), combined Factor V and Factor VIII, Factor VII, Factor X, Factor XI, Factor XII, and Factor XIII deficiencies. This group accounts for 3\u20135% of all factor deficiencies. Different symptoms may occur, ranging from mild or moderate bleeding to serious and life-threatening bleeding, which may not be related to the factor level. This study aimed to evaluate the diagnosis, genetics, treatment, prophylaxis features and surgical experiences of patients those are followed up in our clinic and the review of the literature of rare factor deficiency.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Demographic data, number of follow-up visits throughout the study period, clinical symptoms, number and locations of bleeding symptoms of 19 patients diagnosed with RBD (fibrinogen, prothrombin, FV, FVII, FX, FXI or FXIII) who were followed up in our pediatric hematology clinic between year 2023\u20132024 and complications, inhibitor levels, previous operations, treatment and prophylaxis approaches are recorded in the patient chart and all data had been evaluated retrospectively. In our article, all patients included in this study are mentioned according to the consecutive numbering system as Patient 1(P1) to P19 in Table\u00a02. A comprehensive literature search was performed in PubMed and after primary elections 4 studies are selected from total 23 studies those are most relevant to RBDs in pediatric age as there is only plenty of articles about RBDs. Most of the other studies are reviews without clinical patient trails just including recommadations for diagnosis and laboratuary screenings. In contrast, our study includes a clinical trail on diagnosis, treatment and prophylaxis information of 19 patients with RBDs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The average age of total 19 patients was 11.2 years (range 2,5\u201317 years). 14 patients were boys (74%) and 5 patients were girls (26%). 10 of the patients (52%) had FVII deficiency (mean FVII: 8,3%, range 2,5\u201317%), 4 of patients (21%) had FX deficiency (mean FX:16,2%, range 15\u201317%) and 4 of patients (21%) had FV deficiency (mean FV:14%, range 10\u201317%) and 1 had FXIII deficiency (1%) respectively. The normal range laboratory reference values for rare blood factor levels in our institute (factor V, VII and X deficencies) is 70\u2013120%. In our study group, 63% (12\/19) of our patients were diagnosed over one year of age. Considering all of our cases, skin and soft tissue bleedings are listed as 52% (10\/19), intraoral bleedings as 42% (8\/19), nose bleedings as 63% (12\/19), joint bleedings as 42%(8\/19) and santral nerveous system(CNS) bleedings as 15%(3\/19). Among the serious bleedings of our cases, joint bleeding 42% (8\/19) takes the first place with followed by CNS bleeding 15% (3\/19) and gastro-intestinal system(GIS) bleeding (15%) (3\/19) respectively. Among totally 19 patients, FX deficiency-P17 had a null mutation of FX gene and FV deficiency-P3 had a missense mutation of FV gene has been detected those both were severe deficencies. The medical genetics of the sibling patients with combined FVII deficency and hypofibrinogenemia have been evaluated, but the genetic results have not been completed yet.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We believe that data-based service is required in every clinic and healthcare system for early diagnosis and follow-up of RBDs. Additionially family screenings and more effective genetic counseling may heal the overall survival and prevent further severe complications. Moreover; the missing factor, severity of deficiency, personal and family history of bleeding or thrombosis, availability of treatment options, plasma half-life of infused exogenous clotting factors and infusion frequency, advantages and disadvantages should all be considered before a prophylaxis program or treatment of RBDs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-024-01806-7","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T17:16:10Z","timestamp":1736097370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnosis, treatment, surgical practices and review of the literature in rare coagulation factor deficiencies"],"prefix":"10.1186","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-4600","authenticated-orcid":false,"given":"H\u00fcseyin Avni","family":"Solgun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,5]]},"reference":[{"key":"1806_CR1","doi-asserted-by":"crossref","unstructured":"Peyvandi F, Cattaneo M, Inbal A, De Moerloose P, Spreafico M. Rare bleeding disorders. Haemophilia. 202\u2009\u2013\u200910; 2008.","DOI":"10.1111\/j.1365-2516.2008.01751.x"},{"key":"1806_CR2","first-page":"39","volume":"1","author":"M Manisha","year":"2002","unstructured":"Manisha M, Ghosh K, Shetty S, Nair S, Khare A, Kulkarni B, et al. Spectrum of inherited bleeding disorders from Western India. Haematologia (Budap). 2002;1:39\u201347.","journal-title":"Haematologia (Budap)"},{"key":"1806_CR3","first-page":"33","volume":"2","author":"Z \u015ealc\u0131o\u011flu","year":"2008","unstructured":"\u015ealc\u0131o\u011flu Z, Say\u0131lan \u015een H, Aydo\u011fan G, Ak\u0131c\u0131 F, Ak\u00e7ay A, Tu\u011fcu D, Ba\u015flar Z. Rare factor deficiency; experience of 18 years. J Turkish Pediatr Hematol. 2008;2:33\u20138.","journal-title":"J Turkish Pediatr Hematol"},{"key":"1806_CR4","unstructured":"\u00dcnivar A, Celkan T, F\u0131\u015fg\u0131n T, Belgemen T, Ar CA, Demir M. Nadir Fakt\u00f6r Eksiklikleri Tan\u0131 ve Tedavi K\u0131lavuzu 2013."},{"key":"1806_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/003655100750044802","volume":"60","author":"EM Bladbjerg","year":"2000","unstructured":"Bladbjerg EM, Gram J, Jespersen J. Plasma concen-trations of blood coagulation factor VII measured byimmunochemical and amidolytic methods. Scand J Clin Lab Invest. 2000;60:161\u20138.","journal-title":"Scand J Clin Lab Invest"},{"key":"1806_CR6","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","volume":"125","author":"R Palla","year":"2015","unstructured":"Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood. 2015;125:2052\u201361.","journal-title":"Blood"},{"key":"1806_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.29252\/ibj.23.3.165","volume":"23","author":"S Shahbazi","year":"2019","unstructured":"Shahbazi S, Mahdian R. Factor VII gene defects: review of Functional studies and their clinical implications. Iran Biomed J. 2019;23:165\u201374.","journal-title":"Iran Biomed J"},{"key":"1806_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5505\/tjh.2012.02418","volume":"29","author":"T F\u0131\u015fg\u0131n","year":"2012","unstructured":"F\u0131\u015fg\u0131n T, Balkan C, Celkan T, K\u0131l\u0131n\u00e7 Y, T\u00fcrker M, Timur C, et al. Rare coagulation disorders: a retrospective analysis of 156 patients in Turkey. Turk J Haematol. 2012;29:48\u201354.","journal-title":"Turk J Haematol"},{"key":"1806_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1160\/TH05-05-0337","volume":"94","author":"ED Rosen","year":"2005","unstructured":"Rosen ED, Xu H, Liang Z, Martin JA, Suckow M, Castellino FJ. Generation of genetically-altered mice producing very low levels of coagulation factorVII. Thromb Haemost. 2005;94:493\u20137.","journal-title":"Thromb Haemost"},{"key":"1806_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-2141.1990.00282.x-i1","volume":"74","author":"M Saito","year":"1990","unstructured":"Saito M, Asakura H, Yoshida T, Ito K, Okafuji K, Yoshida T, et al. A familial factor XIII subunit B deficiency. Br J Haematol. 1990;74:290\u20134.","journal-title":"Br J Haematol"},{"issue":"5","key":"1806_CR11","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1111\/hae.13054","volume":"22","author":"T Oda","year":"2016","unstructured":"Oda T, Itoh H, Kawai K, et al. Three successful deliveries involving a woman with congenital afibrinogenaemia\u2014conventional fibrinogen concentrate infusion vs. \u2018as required\u2019 fibrinogen concentrate infusion based on changes in fibrinogen clearance. Haemophilia. 2016;22(5):e478\u201381.","journal-title":"Haemophilia"},{"issue":"2","key":"1806_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1365-2141.2000.01993.x","volume":"109","author":"T Kobayashi","year":"2000","unstructured":"Kobayashi T, Kanayama N, Tokunaga N, et al. Prenatal and peripartum management of congenital afibrinogenaemia. Br J Haematol. 2000;109(2):364\u20136.","journal-title":"Br J Haematol"},{"key":"1806_CR13","doi-asserted-by":"crossref","unstructured":"Cortet M, Deneux-Tharaux C, Dupont C. Association Between Fibrinogen Level and Severity of Postpartum Haemorrhage: Secondary Analysis of a Prospective Trial, Observational Safety Study of Clottafact\u00ae Fibrinogen Concentrate: Real-World Data in Mexico. Br J Anaesth 108(6):984\u20139.","DOI":"10.1093\/bja\/aes096"},{"issue":"3","key":"1806_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/0002-9343(61)90057-2","volume":"30","author":"A De Vries","year":"1961","unstructured":"De Vries A, Rosenberg T, Kochwa S, Boss JH. Precipitating antifibrinogen antibody appearing after fibrinogen infusions in a patient with congenital afibrinogenemia. Am J Med. 1961;30(3):486\u201394.","journal-title":"Am J Med"},{"issue":"05","key":"1806_CR15","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1055\/s-0037-1614201","volume":"91","author":"RA Schuepbach","year":"2004","unstructured":"Schuepbach RA, Meili EO, Schneider E, et al. Lepirudin therapy for thrombotic complications in congenital afibrinogenaemia. Thromb Haemost. 2004;91(05):1044\u20136.","journal-title":"Thromb Haemost"},{"issue":"9","key":"1806_CR16","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/j.1538-7836.2011.04424.x","volume":"9","author":"L Bornikova","year":"2011","unstructured":"Bornikova L, Peyvandi F, Allen G, et al. Fibrinogen replacement therapy for congenital fibrinogen deficiency. J Thromb Haemost. 2011;9(9):1687\u2013704.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1806_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/bjh.13058","volume":"167","author":"AD Mumford","year":"2014","unstructured":"Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014;167(3):304\u201326.","journal-title":"Br J Haematol"},{"issue":"5","key":"1806_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/hae.13825","volume":"25","author":"V Valiton","year":"2019","unstructured":"Valiton V, Hugon-Rodin J, Fontana P, et al. Obstetrical and postpartum complications in women with hereditary fibrinogen disorders: a systematic literature review. Haemophilia. 2019;25(5):747\u201354.","journal-title":"Haemophilia"},{"issue":"1","key":"1806_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MBC.0000000000000514","volume":"28","author":"R Patil","year":"2017","unstructured":"Patil R, Mukaddam A, Ghosh K, Shetty S. Management of pregnancy in dysfibrinogenemia cases: a dilemma. Blood Coagul Fibrinolysis. 2017;28(1):91\u20133.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"1806_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.chest.2016.05.021","volume":"150","author":"M Blondon","year":"2016","unstructured":"Blondon M, Casini A, Hoppe KK, et al. Risks of venous thromboembolism after cesarean sections: a meta-analysis. Chest. 2016;150(3):572\u201396.","journal-title":"Chest"},{"issue":"Suppl 1","key":"1806_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2516.2011.02561.x","volume":"17","author":"FY Huq","year":"2011","unstructured":"Huq FY, Kadir RA. Management of pregnancy, labour and delivery in women with inherited bleeding disorders. Haemophilia. 2011;17(Suppl 1):20\u201330.","journal-title":"Haemophilia"},{"issue":"1","key":"1806_CR22","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1111\/hae.12584","volume":"21","author":"A Lebreton","year":"2015","unstructured":"Lebreton A, Casini A, Alhayek R, et al. Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis. Haemophilia. 2015;21(1):e108\u201310.","journal-title":"Haemophilia"},{"key":"1806_CR23","doi-asserted-by":"crossref","unstructured":"Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus., Mathias M, Pollard D, Riddell A. Prophylaxis in severe prothrombin deficiency. Br J Haematol 2011; 152(2):243\u20134.","DOI":"10.1111\/j.1365-2141.2010.08352.x"},{"key":"1806_CR24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1055\/s-0033-1348948","volume":"39","author":"S Lancellotti","year":"2013","unstructured":"Lancellotti S, Basso M, De Cristofaro R. Congenital prothrombin deficiency: an update. Semin Thromb Hemost. 2013;39:596\u2013606.","journal-title":"Semin Thromb Hemost"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-024-01806-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-024-01806-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-024-01806-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T18:02:01Z","timestamp":1736100121000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-024-01806-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,5]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1806"],"URL":"https:\/\/doi.org\/10.1186\/s13052-024-01806-7","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,5]]},"assertion":[{"value":"26 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Have been taken from Health Sciences University Ethical Committie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent"}},{"value":"Have been taken from the patients\u2019 parents. Patient\u2019s parents gave informed written consent for their personal or clinical details along with any identifying images to be published in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"3"}}